Preparation method and application of calculus bovis factitius based on 3D printing
The preparation of artificial beef shavings through 3D printing technology solves the problems of bilirubin loss and low preparation efficiency, and achieves efficient and low-cost preparation. The appearance and taste of the product are close to that of natural beef shavings, which has high application value.
Patent Information
- Application Number
- CN202410898221.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-05
- Publication Date
- 2024-11-01
AI Technical Summary
The existing artificial beef chlorophyll preparation method results in serious loss of bilirubin, affecting the efficacy of the drug, and the preparation process is inefficient and costly, making it difficult to meet clinical needs.
Using artificial beef ginger preparation method based on 3D printing, the dosage is determined based on the patient's individualized differences, and 3D printing is used for bilirubin calcium precipitation, cholic acid, deoxycholic acid, taurine and other ingredients to reduce the loss of active ingredients and increase the loss of active ingredients. Preparation efficiency.
It realizes efficient retention of bilirubin, reduces preparation costs, and has a fast preparation speed. The appearance and smell of artificial beef shavings are no obvious difference from that of natural beef shavings, and has high application value.
Smart Images

Figure BDA0004929699050000021 
Figure BDA0004929699050000041 
Figure FDA0004929699040000011
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biopharmaceutical technology, and in particular to a method for preparing artificial bezoar based on 3D printing and its application. Background Art
[0002] Bezoar is the dried gallstone of cattle (Bos Taurus domesticus Gmelin). The complete bezoar is mostly oval, light, with a golden to yellow-brown surface, delicate and shiny. According to Chinese medicine, bezoar has a light fragrance, a slightly bitter taste and then sweet, and is cool in nature. It can be used to relieve fever, detoxify, and calm the nerves. It can be taken internally to treat high fever, coma, epilepsy, infantile convulsions, convulsions, etc. It can be used externally to treat sore throat, mouth sores, carbuncle, and toxicity. Since natural bezoar is very precious and its international price is higher than gold, most of the artificial bezoars used are currently used.
[0003] Artificial bezoar is composed of ox bile powder, bile acid, hyodeoxycholic acid, taurine, bilirubin, cholesterol and trace elements. Ox bile powder has a pungent, fishy and bitter taste, bile acid and hyodeoxycholic acid have a bitter taste, and the artificial bezoar composed of these ingredients has a specific pungent, fishy and bitter taste. The method of β-cyclodextrin inclusion of artificial bezoar disclosed in the related art has improved the bad smell of artificial bezoar to a certain extent, thereby improving the taste of taking. However, the above method usually causes the main pharmacological component bilirubin in artificial bezoar to be seriously lost during the inclusion process, so that the bilirubin in the artificial bezoar inclusion compound finally obtained is only about half of the bilirubin content in the raw material sample, thereby seriously affecting the efficacy of artificial bezoar and causing a great waste of materials. In addition, the traditional artificial bezoar preparation process requires a lot of time and human resources, and has low efficiency, which greatly limits its application.
[0004] Based on this, there is an urgent need to seek a new method for preparing artificial bezoar to improve the retention of effective ingredients in bezoar, while reducing preparation costs and improving preparation efficiency. Summary of the invention
[0005] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, the present invention proposes a method and application of preparing artificial bezoar based on 3D printing, which can customize artificial bezoar according to the specific conditions of patients, and has fast preparation speed and high efficiency, can greatly reduce the loss of bilirubin, the effective ingredient in bezoar, and greatly reduce the preparation cost of artificial bezoar.
[0006] The present invention also proposes an artificial bezoar preparation method based on 3D printing and its application in the preparation of medicines.
[0007] The first aspect of the present invention provides a method for preparing artificial bezoar based on 3D printing, comprising the following steps:
[0008] S1. Determine the required dose of bezoar according to individual differences of patients, and prepare a pharmaceutical powder containing calcium bilirubin precipitate, bile acid, deoxycholic acid, taurine, ferrous sulfate, zinc sulfate and magnesium sulfate based on the required dose;
[0009] S2, constructing a three-dimensional model of artificial bezoar and importing it into a dual-nozzle 3D printer;
[0010] S3, using the pharmaceutical powder as a raw material for a first nozzle and a binder as a raw material for a second nozzle, and performing 3D printing to obtain.
[0011] The preparation method according to the embodiment of the present invention has at least the following beneficial effects:
[0012] The artificial bezoar preparation method based on 3D printing of the present invention is simple, can be differentiated and customized according to the specific conditions of the patient, and has fast preparation speed and high efficiency, can greatly reduce the loss of bilirubin, an effective ingredient in bezoar, and greatly reduces the preparation cost of artificial bezoar. In addition, the artificial bezoar prepared by the method of the present invention is brown-yellow in color, fragrant, fine and loose in texture, bitter and then sweet in taste, easy to break when chewed, non-sticky, and has no obvious difference in taste and texture from the natural bezoar, and has extremely high application value.
[0013] In some embodiments of the present invention, the pharmaceutical powder comprises, by weight:
[0014]
[0015] In some embodiments of the present invention, the method for preparing the calcium bilirubin precipitate comprises:
[0016] Bilirubin is dissolved in a solvent, and then a saturated calcium hydroxide solution is added to react to obtain flocs, and finally the flocs are centrifuged, separated, and dried to obtain the product.
[0017] In some embodiments of the present invention, the solvent is selected from at least one of sodium hydroxide, sodium carbonate, and sodium bicarbonate aqueous solution.
[0018] In some embodiments of the present invention, the binder is selected from at least one of a hydroxypropyl methylcellulose aqueous solution or a polyvinyl alcohol aqueous solution.
[0019] In some embodiments of the present invention, the concentration of the binder is 0.2% to 0.5% (w / v).
[0020] In some embodiments of the present invention, the concentration of the hydroxypropyl methylcellulose aqueous solution is 0.2% to 0.5% (w / v).
[0021] In some embodiments of the present invention, the concentration of the polyvinyl alcohol aqueous solution is 0.5% to 1% (w / v).
[0022] In some embodiments of the present invention, the mass ratio of the pharmaceutical powder to the binder is 60-70:40-30.
[0023] In some embodiments of the present invention, the 3D printing adopts a layer-by-layer printing method.
[0024] In some embodiments of the present invention, when single-layer printing is performed, the first nozzle delivers the pharmaceutical powder for spreading, and then the second nozzle delivers the binder for bonding.
[0025] In some embodiments of the present invention, the nozzle diameter of the first nozzle and / or the second nozzle is 0.3 mm to 0.4 mm.
[0026] In some embodiments of the present invention, the spraying speed of the first nozzle and / or the second nozzle is 30-60 mm / s.
[0027] In some embodiments of the present invention, the spray layer height of the first nozzle and the second nozzle is 0.1-0.3 mm.
[0028] In some embodiments of the present invention, the 3D printing temperature is 30-70°C.
[0029] The second aspect of the present invention provides the use of any one of the 3D printing-based artificial bezoar preparation methods of the first aspect in the preparation of drugs. DETAILED DESCRIPTION
[0030] The following will be combined with the embodiments to clearly and completely describe the concept of the present invention and the technical effects produced, so as to fully understand the purpose, characteristics and effects of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work are all within the scope of protection of the present invention.
[0031] The words "preferably", "more preferably", etc. in the present invention refer to embodiments of the present invention that may provide certain beneficial effects in certain circumstances. However, other embodiments may also be preferred under the same circumstances or other circumstances. In addition, the description of one or more preferred embodiments does not imply that other embodiments are not applicable, nor is it intended to exclude other embodiments from the scope of the present invention.
[0032] When a numerical range is disclosed herein, the above range is considered to be continuous and includes the minimum and maximum values of the range, as well as every value between such minimum and maximum values. Further, when a range refers to an integer, every integer between the minimum and maximum values of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be combined. In other words, unless otherwise indicated, all ranges disclosed herein should be understood to include any and all subranges included therein.
[0033] In the description of the present invention, the reference term "and / or" includes all and any combinations of one or more of the associated listed items.
[0034] In the description of the present invention, the description with reference to the terms "one embodiment", "some embodiments", "illustrative embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner.
[0035] If the specific conditions are not specified in the examples, the experiments were carried out under conventional conditions or conditions recommended by the manufacturer. If the manufacturers of the reagents or instruments are not specified, they are all conventional products that can be purchased commercially.
[0036] Example 1
[0037] This embodiment provides a method for preparing bezoar based on 3D printing, which specifically includes the following steps:
[0038] Step S1: Determine the precise dosage of the drug required by the patient according to individual differences of the patient and relevant physiological indicators, and determine, by weight fraction, that the raw materials for preparing the required artificial bezoar include the following components:
[0039]
[0040] The preparation method of calcium bilirubin precipitate is as follows: 1 g of bilirubin is dissolved in 600 mL of 10 mM sodium hydroxide solution, and then 600 mL of saturated calcium hydroxide solution is added, stirred to react to obtain flocs, and finally the flocs are centrifuged, separated, and dried to obtain the precipitate.
[0041] The hydroxypropyl methylcellulose aqueous solution is a 0.2% hydroxypropyl methylcellulose aqueous solution.
[0042] Step S2, connect the powder-liquid type 3D printer with the main control computer, turn on the main control computer to input the component information of artificial bezoar required for the patient, build the artificial bezoar three-dimensional model at the same time, and save the model as the digital model of the STL format; then import the model of the STL format into the slicing software for calculation, and generate the G code (for controlling the nozzle path) and import it into the printer;
[0043] Step S3, according to the above-mentioned parts by weight, the artificial bezoar preparation raw material bilirubin calcium precipitate, bile acid, deoxycholic acid, taurine, ferrous sulfate, zinc sulfate and magnesium sulfate in step S1 are mixed, and a pharmaceutical powder (as a forming material) is obtained after passing through a 100-mesh sieve, and then the obtained pharmaceutical powder is injected into a first syringe of a powder-liquid 3D printing device, and the first syringe is connected to the first nozzle through a pipeline; at the same time, the above-mentioned preparation raw material hydroxypropyl methylcellulose aqueous solution is injected into a second syringe of the 3D printing device as a binder component, and the second syringe is connected to the second nozzle through a pipeline;
[0044] Step S4, at 60°C, pre-set the powder-liquid 3D printing molding parameters, use the above-mentioned drug powder as the printing molding material, transport it to the powder-liquid 3D printing platform for powder spreading, and move the first nozzle and the second nozzle of the 3D printing system in the XY axis direction, spray the binder according to the spraying cross-sectional profile, and bond the powder into a layered sheet, wherein the nozzle diameter of the first nozzle and the second nozzle is about 0.25-0.3mm, the spraying speed is about 25-35mm / s, and the single spraying layer height is about 0.15mm; in addition, in the Z-axis direction, the printing platform is lowered as a whole by the spraying layer height through the movement of the shaft body, and printing is repeated until the set spraying thickness is reached.
[0045] Test example
[0046] In this test example, the appearance of the artificial bezoar prepared in the above-mentioned Example 1 was observed, and the total bilirubin content, free bilirubin content and bile acid content therein were further tested.
[0047] (1) Observation of appearance
[0048] The appearance of the artificial bezoar prepared in the above embodiment 1 was observed, and the results showed that the 3D printed artificial bezoar prepared by the present invention was brown-yellow in color, fragrant, fine and loose in texture, bitter and then sweet in taste, easy to break when chewed, not sticky to teeth, and had no obvious difference in taste from the natural bezoar; further, a small amount of the bezoar prepared in embodiment 1 was ground with water on the nails, showing yellow color, commonly known as "hanging nails", which was equivalent to the natural bezoar hanging nail effect.
[0049] (2) Determination of total bilirubin content
[0050] The total bilirubin content of the artificial bezoar obtained in above-mentioned embodiment 1 was measured, and the specific method was as follows:
[0051] First, take a small amount of artificial bezoar prepared above (about 10mg), grind it into fine powder, put it in a conical flask, add 60mL of chloroform-ethanol (7:3) mixed solution and 1 drop of hydrochloric acid (concentration 12M), shake well, place it in a water bath (100℃) and heat it under reflux for 30 minutes, let it cool, transfer it to a 100mL brown volumetric flask, wash the container with a small amount of the above mixed solution, add the washing liquid to the same volumetric flask, add the above mixed solution to the scale, and shake well. Accurately measure 10ml of the supernatant, place it in a 50ml brown volumetric flask, add ethanol to the scale, and shake well. Accurately measure 3ml, place it in a stoppered test tube, and measure the absorbance according to the method under the preparation of the standard curve, starting from "add ethanol to 9mL", read the weight (mg) of bilirubin in the test solution from the standard curve, and calculate it. Perform three experiments in parallel and take the average value.
[0052] The test results show that the total bilirubin content in the artificial bezoar prepared by the method of Example 1 is 49.97%, and the retention rate of bilirubin reaches more than 99%. It can be seen that the method of the present invention can effectively reduce the loss of bilirubin, the main medicinal component in artificial bezoar.
[0053] (2) Determination of free bilirubin content
[0054] The free bilirubin content of the artificial bezoar obtained in above-mentioned embodiment 1 was measured, and the specific method was as follows:
[0055] First, take a small amount of artificial bezoar prepared above (about 10 mg), grind it into fine powder, put it in a 5 mL volumetric flask, add 4 mL of chloroform, warm it slightly, let it cool, add chloroform to the scale, shake it well, filter it, take the filtrate, and measure the absorbance at a wavelength of 453 mm according to the UV-visible spectrophotometry. The absorbance must not exceed 0.70. Perform three experiments in parallel and take the average value.
[0056] The test results show that no free bilirubin was detected in the artificial bezoar prepared by the method of Example 1. Generally, free bilirubin has strong fat solubility and can pass through the blood-brain barrier, which may have toxic side effects on the human body. Artificial bezoar with low free bilirubin content or without free bilirubin is relatively safer.
[0057] (3) Determination of bile acid content
[0058] The free bilirubin content of the artificial bezoar obtained in above-mentioned embodiment 1 was measured, and the specific method was as follows:
[0059] First, take a small amount of artificial bezoar prepared above (about 10 mg), grind it into fine powder, add a little 60% acetic acid and dissolve it by ultrasonic. Transfer it into a 25mL volumetric flask, dilute it to the scale with 60% acetic acid solution, and shake it well. Take 1mL of the sample solution, add 1mL of freshly prepared 1% furfural aqueous solution, place it in an ice bath for 5 minutes, add 13mL of sulfuric acid solution, keep it in a 70℃ water bath for 10 minutes, take it out, immediately place it in an ice bath for 2 minutes, measure the absorbance at a wavelength of 605mm, and check the corresponding bile acid amount from the standard curve.
[0060] The results showed that the bile acid content in the artificial bezoar prepared by the method of Example 1 was 13.93%.
[0061] The above is a detailed description of the embodiments of the present invention, but the present invention is not limited to the above embodiments. Various changes can be made within the knowledge of ordinary technicians in the relevant technical field without departing from the purpose of the present invention. In addition, the embodiments of the present invention and the features in the embodiments can be combined with each other without conflict.
Claims
1. A method for preparing artificial bezoar based on 3D printing, characterized in that: The following steps are involved: S1. Determine the required dose of bezoar according to individual differences of patients, and prepare a pharmaceutical powder containing calcium bilirubin precipitate, bile acid, deoxycholic acid, taurine, ferrous sulfate, zinc sulfate and magnesium sulfate based on the required dose; S2, constructing a three-dimensional model of artificial bezoar and importing it into a dual-nozzle 3D printer; S3, using the pharmaceutical powder as a raw material for a first nozzle and a binder as a raw material for a second nozzle, and performing 3D printing to obtain.
2. The method for preparing artificial bezoar according to claim 1, wherein The pharmaceutical powder comprises, by weight:
3. The method for preparing artificial bezoar according to claim 1, wherein The preparation method of the calcium bilirubin precipitate comprises: dissolving bilirubin in a solvent, then adding a saturated calcium hydroxide solution, reacting, collecting the precipitate, and drying the precipitate.
4. The method for preparing artificial bezoar according to claim 1, wherein The binder is selected from at least one of a hydroxypropyl methylcellulose aqueous solution and a polyvinyl alcohol aqueous solution.
5. The method for preparing artificial bezoar according to claim 4, wherein: The concentration of the binder is 0.2% to 1% w / v.
6. The method for preparing artificial bezoar according to claim 1, wherein: The mass ratio of the pharmaceutical powder to the binder is 60-70:40-30.
7. The method for preparing artificial bezoar according to claim 1, wherein: The 3D printing adopts a layer-by-layer printing method; Preferably, when single-layer printing is performed, the first nozzle delivers the pharmaceutical powder for spreading, and then the second nozzle delivers the adhesive for bonding.
8. The method for preparing artificial bezoar according to claim 1, wherein: The nozzle diameter of the first nozzle and / or the second nozzle is 0.2-0.4 mm; Preferably, the spraying speed of the first nozzle and / or the second nozzle is 20 to 40 mm / s; Preferably, the spray layer height of the first nozzle and the second nozzle is 0.1-0.2 mm.
9. The method for preparing artificial bezoar according to any one of claims 1 to 8, characterized in that: The 3D printing temperature is 50-65°C.
10. Use of the method for preparing artificial bezoar according to any one of claims 1 to 9 in preparing medicines.
Citation Information
Patent Citations
Artificial bezoar and preparation method thereof
CN101530428A
Novel method for preparing calculus bovis factitius and raw materials thereof
CN104083405A
A manufacturing method of traditional Chinese medicines or medicined diets based on 3D printing
CN104886738A
Cited By
Method for preparing high-bionic calculus bovis by utilizing 3D printing technology and application of high-bionic calculus bovis
CN118845839A
A method for preparing high-bionic bovine bezoar by using 3D printing technology and application
CN118845839B
